Atropine Sulfate Monohydrate CAS: 5908-99-6

CAS NO: 5908-99-6
Atropine Sulfate Monohydrate
Chemical Name: Atropine sulfate monohydrate
Molecular Formula: C17H25NO7S
Formula Weight: 387.45
CAS No.: 5908-99-6
Description Review
Description

Atropine Sulfate Monohydrate is a medication used in emergency situations such as heart attack or poisoning to increase heart rate and reduce secretion of bodily fluids. It is also used in surgery to reduce saliva production and prevent reflex bradycardia.

Chemical Name:

The chemical name of Atropine Sulfate Monohydrate is (RS)-3-[(Hydroxyphenylacetyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane-8-carboxylic acid sulfate monohydrate.

Molecular Formula:

The molecular formula of Atropine Sulfate Monohydrate is C17H24N2O3.H2SO4.H2O.

Formula Weight:

The formula weight of Atropine Sulfate Monohydrate is 694.81 g/mol.

CAS No:

The CAS number of Atropine Sulfate Monohydrate is 5908-99-6.

Top Ten Keywords from Google and Synonyms:

  1. Emergency medication
  2. Atropine Sulfate Monohydrate
  3. Heart attack treatment
  4. Antidote for poisoning
  5. Surgery medication
  6. Saliva reduction drug
  7. Reflex bradycardia prevention
  8. Cardiac stimulant
  9. Muscarinic antagonist
  10. Parasympatholytic agent

Synonyms: Atrosulf, Atropsulf, Atroject, Atropine Sulfate Hydrate

Health Benefits of Atropine Sulfate Monohydrate:

Atropine Sulfate Monohydrate is primarily used in emergency situations such as heart attack or poisoning. It helps in increasing heart rate, reducing secretion of bodily fluids and preventing reflex bradycardia. Additionally, it can be used in surgery to reduce saliva production.

Potential Effects:

Atropine Sulfate Monohydrate is a muscarinic antagonist that blocks the effects of acetylcholine on the parasympathetic nervous system. By doing so, it increases heart rate, reduces saliva production and prevents reflex bradycardia. This medication can also have an effect on the respiratory system, producing bronchodilation and reducing secretions.

Product Mechanism:

Atropine Sulfate Monohydrate works by competitively blocking the effects of acetylcholine on the muscarinic receptor sites. This action results in a decrease in parasympathetic activity, leading to an increase in heart rate and reduced salivary and bronchial secretions. The exact mechanism of action is complex, and the effects of atropine sulfate can vary depending on the dose and route of administration.

Safety:

Atropine Sulfate Monohydrate is generally considered safe when used as directed. However, like all medications, it may cause side effects in some people. It is not recommended for certain patients, such as those with narrow-angle glaucoma, obstructive uropathy, or ulcerative colitis. It should also be used with caution in people with asthma, pregnancy, or lactation.

Side Effects:

Common side effects of Atropine Sulfate Monohydrate include dry mouth, blurred vision, and urinary retention. Rare but serious side effects may include tachycardia, hypertension, and confusion. Patients who experience any of these symptoms should seek immediate medical attention.

Dosing Information:

The recommended dose of Atropine Sulfate Monohydrate depends on the condition being treated and the individual patient's response to the medication. In emergency situations such as cardiac arrest or poisoning, the usual dose is 0.5-1 mg intravenously every 3-5 minutes as needed. In surgery, the recommended dose is typically 0.4-0.6 mg administered subcutaneously or intramuscularly.

Conclusion:

Atropine Sulfate Monohydrate is a medication used in emergency situations such as heart attack or poisoning to increase heart rate and reduce secretion of bodily fluids. It is also used in surgery to reduce saliva production and prevent reflex bradycardia. While it is generally safe and effective, it may cause side effects in some patients and is not recommended for certain populations. If you have any questions about Atropine Sulfate Monohydrate or its use, please consult your healthcare provider.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code